Literature DB >> 23085131

Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients.

Javier Jiménez-Candil1, Jesús Hernández, Ana Martín, José Moríñigo, Rosana López, Claudio Ledesma, Cándido Martín-Luengo.   

Abstract

BACKGROUND: Antitachycardia pacing (ATP) fails to terminate 5% to 25% of ventricular tachycardias (VTs) occurring in implantable cardioverter-defibrillator patients. We speculated that small fluctuations in VT cycle length (CL) may be related to the efficacy of subsequent ATP.
OBJECTIVE: The purpose of this study was to determine the relationship between the R-R variations of the last 12 R-R intervals before ATP and the efficacy of the first ATP attempt.
METHODS: We studied 551 VTs (CL 329±35 ms) occurring in 67 patients. We also analyzed the percentage of variation (P-RR), which was calculated by dividing the mean difference between each R-R interval and the next one by the CL (×100), and the acceleration index (AI), which was calculated by dividing the CL of the first 6 R-R intervals by the CL of the next 6.
RESULTS: The effectiveness of the first ATP therapy was 81%, being higher in VTs with AI<1 (85% vs 64%; P<.001). After classifying the events according to the tertiles of P-RR, ATP efficiency was better in higher values of P-RR (VTs with AI<1): 99% (third tertile) vs 85% (second tertile) vs 76% (first tertile), P<.001; and for VTs with AI≥1: 94% vs 68% vs 42% (P<.001). By logistic regression, P-RR (%; odds ratio 2.37; P<.001), and AI<1 (odds ratio 4.17; P<.001) were found to be independent predictors of successful first ATP attempts.
CONCLUSION: Small changes in CL increase the effectiveness of ATP significantly. VTs with lower degrees of R-R fluctuations, especially when the pattern is a progressive CL shortening, are infrequently terminated by ATP.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23085131     DOI: 10.1016/j.hrthm.2012.10.028

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  7 in total

1.  Differences in ventricular tachyarrythmias and antitachycardia pacing effectiveness according to the ICD indication (primary versus secondary prevention): an analysis based on the stored electrograms.

Authors:  Javier Jiménez-Candil; Jesús Hernández; Ana Martín; José Moríñigo; Pedro Perdiguero; Loreto Bravo; Sonia Ruiz; Pedro L Sánchez
Journal:  J Interv Card Electrophysiol       Date:  2015-08-26       Impact factor: 1.900

2.  Effectiveness of first versus successive antitachycardia pacing attempts: predictors and clinical consequences.

Authors:  Javier Jiménez-Candil; Olga Durán; Jean Núñez; Loreto Bravo; Jesús Hernández; Ana Martín-García; José Morínigo; Pedro L Sánchez
Journal:  J Interv Card Electrophysiol       Date:  2019-09-16       Impact factor: 1.900

3.  Non-response to implantable cardioverter defibrillator in a post-infarction patient with recurrent ventricular tachycardia after catheter ablation.

Authors:  Xiang-Fei Feng; Jian Sun; Jun Wang; Yi-Gang Li
Journal:  Chin Med J (Engl)       Date:  2015-02-05       Impact factor: 2.628

4.  Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.

Authors:  Angel Arenal; Alessandro Proclemer; Axel Kloppe; Maurizio Lunati; José Bautista Martìnez Ferrer; Ahmad Hersi; Marcin Gulaj; Maurits C E F Wijffels; Elisabetta Santi; Laura Manotta; Lorenza Mangoni; Maurizio Gasparini
Journal:  Europace       Date:  2016-08-02       Impact factor: 5.214

5.  RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy.

Authors:  Keita Tsukahara; Yasushi Oginosawa; Yoshihisa Fujino; Toshihiro Honda; Kan Kikuchi; Masatsugu Nozoe; Takayuki Uchida; Hitoshi Minamiguchi; Koichiro Sonoda; Masahiro Ogawa; Takeshi Ideguchi; Yoshihisa Kizaki; Toshihiro Nakamura; Kageyuki Oba; Satoshi Higa; Keiki Yoshida; Keishiro Yagyu; Taro Miyamoto; Yasunobu Yamagishi; Hisaharu Ohe; Ritsuko Kohno; Masaharu Kataoka; Yutaka Otsuji; Haruhiko Abe
Journal:  J Arrhythm       Date:  2021-05-18

6.  What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes.

Authors:  Yin Fang; Kai Gu; Bing Yang; Weizhu Ju; Hongwu Chen; Mingfang Li; Hailei Liu; Jiaxian Wang; Gang Yang; Minglong Chen
Journal:  J Arrhythm       Date:  2017-12-14

7.  Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies.

Authors:  Javier Jiménez-Candil; Olga Duran; Armando Oterino; Jendri Pérez; Juan Carlos Castro; Jesús Hernández; José Moríñigo; Manuel Sánchez García; Pedro L Sánchez
Journal:  BMC Cardiovasc Disord       Date:  2021-05-31       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.